215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

Authors :: Firouzeh Korangy
Lars A. Ormandy
Gisèle N'Kontchou
M.P. Manns
Tim F. Greten
Nathalie Barget
C. Ayuso
Jordi Bruix
Alejandro Forner
Michel Beaugrand
Source :: Journal of Hepatology. 52:S92
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: chemistry.chemical_classification
Oncology
medicine.medical_specialty
Telomerase
Hepatology
business.industry
Peptide
medicine.disease
Vaccination
chemistry
Hepatocellular carcinoma
Internal medicine
medicine
In patient
Open label
business

Full Text Access

Tools